A flow diverting apparatus for chronic inflammation and lymphedema

A method of treating and/or preventing chronic inflammation in a patient comprising:

• implanting a flow diverting apparatus in a primary arterial vessel of a patient, the flow diverting apparatus including an inlet opening and an outlet opening, wherein the flow diverting apparatus is implanted such that the inlet opening is positioned within the primary arterial vessel upstream an orifice of a secondary branch vessel that branches off of the primary arterial vessel and the outlet opening is positioned at, upstream, or downstream the orifice,
• wherein the implanted flow diverting apparatus is positioned and configured such that a proportion of inflammation-causing components in blood of the patient in the primary arterial vessel upstream the flow diverting apparatus being directed away from the secondary branch vessel is greater than a proportion of the inflammation-causing components in the blood of the patient in the primary arterial vessel upstream the flow diverting apparatus being directed towards the secondary branch vessel, and
• wherein the secondary branch vessel leads to a portion of a body of the patient affected with chronic inflammation.

A method of treating and/or preventing lymphedema or chronic inflammation in a patient comprising:

• implanting a flow diverting apparatus in an infrarenal aorta of the patient such that the flow diverting apparatus is positioned upstream orifices of right and left common iliac arteries,
• wherein the implanted flow diverting apparatus is positioned and configured such that a greater proportion of blood or a greater proportion of inflammation-causing components of the blood of the patient, is directed from the infrarenal aorta to the orifice of the right common iliac artery or the left common iliac artery as compared to the orifice of the other of the right common iliac artery or the left common iliac artery, and
• wherein the other of the right common iliac artery or the left common iliac artery leads to a lower limb of the patient affected with lymphedema or chronic inflammation.